Details for New Drug Application (NDA): 214557
✉ Email this page to a colleague
The generic ingredient in VARENICLINE TARTRATE is varenicline tartrate. There are twelve drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the varenicline tartrate profile page.
Summary for 214557
Tradename: | VARENICLINE TARTRATE |
Applicant: | Alkem Labs Ltd |
Ingredient: | varenicline tartrate |
Patents: | 0 |
Pharmacology for NDA: 214557
Mechanism of Action | Cholinergic Agonists Partial Cholinergic Nicotinic Agonists |
Medical Subject Heading (MeSH) Categories for 214557
Suppliers and Packaging for NDA: 214557
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
VARENICLINE TARTRATE | varenicline tartrate | TABLET;ORAL | 214557 | ANDA | Major Pharmaceuticals | 0904-7413 | 0904-7413-35 | 56 TABLET, FILM COATED in 1 BOTTLE (0904-7413-35) |
VARENICLINE TARTRATE | varenicline tartrate | TABLET;ORAL | 214557 | ANDA | Major Pharmaceuticals | 0904-7414 | 0904-7414-35 | 56 TABLET, FILM COATED in 1 BOTTLE (0904-7414-35) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 0.5MG BASE | ||||
Approval Date: | Aug 23, 2023 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 1MG BASE | ||||
Approval Date: | Aug 23, 2023 | TE: | AB | RLD: | No |
Complete Access Available with Subscription